FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly ophthalmology, and may be used for treating inflammatory and dystrophic eye diseases. If observing an anterior segment of an eyeball, therapeutic agents are administered subcutaneously into a temporal region 1.8-2.2 cm above the middle of a cheek bone into a lymphatic capillary accumulation. If observing a posterior segment of the eyeball, the therapeutic agents are administered subcutaneously 0.8-1.2 cm below the top of a mastoid bone, as well as into the lymphatic capillary accumulation. Heparin in a single dose of 0.3 to 0.6 ml with the therapeutic substance concentration of 96% to 100% is initially administered into the above regions. The basic substance solution in a single dose of 0.6 to 0.8 ml with the therapeutic substance concentration of 45% to 55% is administered thereafter. That is followed by administering Contrykal in a single dose of 0.4 to 0.6 ml with the substance concentration of 45% to 55%. The manipulations are daily for 7-10 days with the therapeutic course repeated every 1-6 months.
EFFECT: method provides better trophism and microcirculation of an optic disk and retina, lower intensity of pathological reactions with obtaining the therapeutic substance concentrations faster, reducing injuries of the manipulation and doses of the administered preparations.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING OPTICAL NERVE ATROPHY | 1991 |
|
RU2012295C1 |
METHOD FOR TREATING UVEITIS IN CHILDREN | 1999 |
|
RU2185193C2 |
METHOD OF TREATING ISCHEMIC TYPE OF PRIMARY OPEN-ANGLE GLAUCOMA IN INDIVIDUALS WITH NEAT SIGHT | 2010 |
|
RU2438670C1 |
METHOD FOR THE TREATMENT OF OPTIC NEUROPATHY IN PATIENTS WITH EDEMATOUS EXOPHTHALMOS | 2020 |
|
RU2742188C1 |
LYMPHOTROPIC THERAPY METHOD FOR TREATING PATIENTS FOR OPEN ANGLE GLAUCOMA WITH NORMALIZED INTRAOCULAR PRESSURE | 2002 |
|
RU2212211C1 |
METHOD FOR TREATING PRIMARY OPEN ANGLE GLAUCOMA | 2006 |
|
RU2320308C1 |
METHOD OF TREATING DEGENERATIVE AND DYSTROPHIC RETINAL DISEASES | 2012 |
|
RU2495669C1 |
METHOD FOR TREATMENT OF GLAUCOMA OPTICAL NEUROPATHY | 2005 |
|
RU2284192C1 |
METHOD OF TREATING RETINAL AND VITREOUS HEMORRHAGE | 2013 |
|
RU2513473C1 |
METHOD OF TREATING INFLAMMATORY OR DYSTROPHIC EYE DISEASES | 2019 |
|
RU2714193C1 |
Authors
Dates
2014-03-10—Published
2012-10-08—Filed